European Psychiatry - Volume 33 - March 2016

396 / 812

S392 24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805
to collecting demographic data including self-report about discon-
tinuation of the treatment in past.
Results We examined data from 99 patients (54 males) suffering
from severe mental disorders and 86 patients (41 males) suffer-
ing from anxiety spectrum disorders. There were no statistically
significant differences between these two groups in gender, age,
education or marital status. In both groups, we proved signifi-
cant correlation between level of self-stigmatization and adherence
to treatment (r= −0.320, respectively r = −0.432). Up to our
results, there were no statistically significant differences between
both groups in level of self-stigmatization (P= 0.656), adher-
ence to treatment (P= 0.474) and discontinuation of medication
(P= 0.231).
Conclusions Level of self-stigmatization proved to be an
important factor in influencing both level of adherence and
discontinuation of drugs in both subgroups of patients. There
were no differences between self-stigmatization or adherence
between subgroups. More attention should be paid to issue of
self-stigmatization throughout whole diagnostic spectrum of psy-
chiatric patients.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV131
Gender differences in anxiety among
secondary school in Kuwait
S. Kareemi
Kuwait University, Faculty of Social Sciences, Psychology, Kaifan,
Kuwait
Introduction Anxiety disorders are themost commonmental dis-
orders, and their prevalence is substantially higher in women than
inmen. Research has confirmed the existence of gender differences
in several types of anxiety disorders.
Objectives The current investigation sought to determine
whether any observable gender differences existed in anxiety for a
nonclinical sample.
Methods the sample consisted of 300 males and 300 female
students from a secondary school in Kuwait. The genders were
matched in age (males = 16.52 ± 0.90 & females = 16.37± 0.96,
t = 1.93, P> .05). The inclusion criteria for all participants: sample
of the population of Al-Jahra city, aged between 15 and 18 years
old, school grades 10, 11, 12, and the social status of the parents
(married). The Arabic version of Beck Anxiety Inventory (BAI) was
administered to participants. BAI reliabilities ranged from .88 to
.87 with a mean .87 (alpha) denoting good internal consistency.
The convergent correlations in eight samples between BAI and
Kuwait University Anxiety Scale KUAS (mean r = .52) for validity
coefficients.
Results The results revealed that females (18.67 ±11.11) had sig-
nificantly higher mean anxiety than their male (14.52 ± 10.37)
counterparts ( f= 22.27, P < .000).
Conclusion Therefore, we can conclude that female preponder-
ance of anxiety has been a consistent finding within literature.
Disclosure of interest The author has not supplied his declaration
of competing interest.
EV132
A research on anxiety disorder
prevalence and severity among
vestibuler migraine and migraine
patients
Ö. Kutay Yüksel ∗, G. Akdal , T. Alkın , B. Dönmez Balcı
1 Dokuz Eylul University, Clinical Neuroscience, Izmir, Turkey
2 Dokuz Eylul University, Neurology, Izmir, Turkey
3 Dokuz Eylul University, Psychiatry, Izmir, Turkey
∗ Corresponding author.
In this research, anxiety, depression symptoms and severity were
compared between healthy controls (HC), vestibulermigraine (VM)
and migraine patients without history of vertigo (MO).
Method Thirty-five definite vestibulermigraine patients (accord-
ing to Neuhauser criteria), 35 MO patients and 32 healthy
controls were included. All patients were evaluated for their life-
time psychiatric disorders with Structured Clinical Interview for
DSM–IV/Clinical version (SCID-I/CV). All three groups evaluated by:
– Hamilton Anxiety Rating Scale (HARS);
– State-Trait Anxiety Inventory (STAI), (STAI-X1) and the other trait
anxiety STAI-X2);
– Beck depression inventory (BDI);
– Lifetime Panic Agoraphobic Spectrum Scale (PAS-SR);
– Penn State Worry Questionnaire (PENN);
– Separation Anxiety Symptoms Inventory (SASI);
– Adult Separation Anxiety Questionnaire (ASA).
Psychiatric diagnosis history (SCID-I); comparison of VM and MO
did not indicate a significant difference (P < 0.05). VM and MO
patients were significantly different than HC in terms of anxiety
symptoms in “HAM-A, PENN, ASA, PAS-SR and PAS-SR subscales
(P < 0.05)”. VM was significantly different than MO patients in
BDE and PAS-SR (overall; separation anxiety, agoraphobia, reas-
surance seeking) (P< 0.05). The longer the history of migraine the
higher was the anxiety points in both in VM and MO patients
(P < 0.05). Headache and vertigo severity inVMpatientswere signif-
icantly correlated with the elevated anxiety and depression points
(P < 0.05).
Conclusion VM and MO patients significantly different in anxi-
ety and mood disorder when compared with healthy controls. Our
findings showed that VM patients were more vulnerable to psychi-
atric disorders. For that reason, multidisciplinary approach for the
treatment of VM may facilitate the treatment process.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV133
The Balkan region preferences for the
treatment of anxiety disorders
M. Latas ∗, D. Bonevski , A. Andromahi Naumovska
1 Belgrade, Serbia
2 Пcихиjɑtриcкɑ болh иц ɑ “Cкопje”, Цehtɑр зɑ мehtɑ лh о здрɑвje
“Цehtɑр”, Skopje, The Former Yugoslav Republic of Macedonia
∗ Corresponding author.
Themost countries fromWest Balkan region do not have the official
guidelines for the treatment of patientswith anxiety disorders (AD).
We have done the survey on preferences of treatment of patients
with AD. We have collected data from sample of 221 psychiatrists
from Croatia (41 psychiatrists), Macedonia (81 psychiatrists) and
Serbia (99 psychiatrists). They give as information about their pref-
erences for treating patients with AD.
The results indicate that the vast majority of psychiatrists report
that almost all patients with AD receive benzodiazepines prior
to first psychiatric visit. The majority of psychiatrist would opt
for SSRI/SNRI antidepressants (91–97%) as the monotherapy or in
combination with benzodiazepines (53–59%) or in combination
with cognitive-behavior (25–35%) or psychodynamic psychother-
apy (12–16%).
The most indicative difference between psychiatrists from differ-
ent countries is result about the use of pregabalin – almost half of
Serbian subsample would opt for pregabalin, but only a quarter of
Croatian subsample and no psychiatrist fromMacedonian subsam-
ple would choose pregabalin. Also, much more Macedonian and
Serbian psychiatrist would opt for CBT treatment, but, in contrast,
much more Croatian psychiatrist would opt for psychodynamic